Suppr超能文献

高血压急症中舌下含服卡托普利与硝苯地平的比较

[Sublingually administered captopril versus nifedipine in hypertension emergencies].

作者信息

Guerrera G, Melina D, Capaldi L, Mauro R, Colivicchi F, Cardillo C, Guerrera G, Musumeci V, Savi L, Santoliquido A

机构信息

Istituto di Patologia Speciale Medica, Università Cattolica del Sacro Cuore, Roma.

出版信息

Minerva Cardioangiol. 1990 Jan-Feb;38(1-2):37-44.

PMID:2188165
Abstract

Aim of the study was to assess the effectiveness and tolerability of sublingual captopril (SLC) versus sublingual nifedipine (SLN) in treating hypertensive emergencies. During hypertensive crises (systolic blood pressure exceeding 200 mmHg and diastolic blood pressure exceeding 115 mmHg) forty hypertensive patients received either 25 mg of SLC or 10 mg of SLN in a randomized single blind fashion. Blood pressure and heart rate were then controlled after 5, 10, 15, 20, 30, 45, 60, 120 min. and, in 18 cases, up to the 8th hour from the administration. Our results showed: 1) a satisfactory control of the hypertensive crises in 80% of patients treated with SLC with a significant blood pressure reduction after 10 min. (13/8 mmHg, p less than 0.02), while the maximum hypotensive effect was achieved after 30 min. (52/36 mmHg, p less than 0.001); SLN was able to reduce blood pressure in 90% of all the cases, with a significant reduction after 5 min. (15/11 mmHg, p less than 0.02) and hypotensive peak after 20 min (57/38 mmHg, p greater than 0.001); 2) no significant differences for hypotensive effectiveness between the two groups, but with SLC having a mildly delayed onset of action when compared to SLN; 3) antihypertensive effect lasting for about 6 hours in patients treated with SLC and blood pressure progressively raising after 4 hours in patients who received SLN; 4) a significant correlation between blood pressure reduction and blood pressure before drug administration in both groups; a significant correlation between pretreatment PRA and antihypertensive effect in the SLC group. We conclude that both drugs are effective and useful in treating hypertensive emergencies. Anyway we think that in severe forms SLN should be preferred for the shorter time preceding onset of action.

摘要

本研究的目的是评估舌下含服卡托普利(SLC)与舌下含服硝苯地平(SLN)治疗高血压急症的有效性和耐受性。在高血压危象期间(收缩压超过200 mmHg且舒张压超过115 mmHg),40例高血压患者以随机单盲方式接受25 mg SLC或10 mg SLN。然后在5、10、15、20、30、45、60、120分钟后以及18例患者中在给药后长达8小时控制血压和心率。我们的结果显示:1)80%接受SLC治疗的患者高血压危象得到满意控制,10分钟后血压显著降低(13/8 mmHg,p小于0.02),而最大降压效果在30分钟后达到(52/36 mmHg,p小于0.001);SLN能够使90%的病例血压降低,5分钟后显著降低(15/11 mmHg,p小于0.02),20分钟后达到降压峰值(57/38 mmHg,p大于0.001);2)两组降压效果无显著差异,但与SLN相比,SLC起效稍延迟;3)接受SLC治疗的患者降压作用持续约6小时,接受SLN治疗的患者4小时后血压逐渐升高;4)两组血压降低与给药前血压之间存在显著相关性;SLC组治疗前血浆肾素活性(PRA)与降压效果之间存在显著相关性。我们得出结论,两种药物在治疗高血压急症方面均有效且有用。无论如何,我们认为在严重形式的高血压急症中,由于SLN起效时间较短,应优先选用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验